AB Analysts Trim Targets as Shorts Quietly Build

AllianceBernstein Holding L.P. heads into its November 18 earnings with a tightening analyst consensus and a short position that has grown quietly but steadily over the past month.

The analyst picture has turned more cautious. TD Cowen cut its target to $35 today, the second reduction in three weeks, leaving the stock with almost no implied upside at the current price of $35.29. Barclays trimmed to $37 earlier this month. Evercore ISI, the only outperform-rated firm in the group, pulled its target back from $42 to $39 in early October. None of these moves involved a rating change. The Street is not turning bearish outright, but analysts are steadily walking targets lower toward where the stock already trades. The consensus mean is $36.86, barely 4% above the close.

Short positioning tells a more interesting sub-story than the headline number suggests. At 1.6% of free float, the absolute level is low. But the directional move is notable: short interest has risen 66% over the past month, roughly doubling from about 870,000 shares in mid-September to around 1.42 million now. That build has happened quietly, without the kind of borrow squeeze that would make it expensive. Cost to borrow is just 0.54%, well within normal territory. Availability has actually loosened over the past week to 176%, meaning there are roughly 1.75 shares available to borrow for every one already shorted. The lending market is not under stress. Shorts are adding exposure at little cost, and there is plenty of room for more.

Options positioning leans decisively bullish in the near term. The put/call ratio is 0.23, nearly 1.8 standard deviations below its 20-day average of 0.24, making it one of the more call-heavy readings of the past year. The 52-week low is 0.09 and the high 0.79, so current positioning is firmly in the bullish half of the range. That stands in direct contrast to the short interest build: options traders are leaning into upside, while short sellers have been adding quietly on the other side.

The factor picture adds nuance to the Street's cautious tone. Forward earnings momentum is weak. The 30-day EPS momentum score ranks in the 27th percentile, and the 90-day reading is even lower at the 22nd percentile. On the value side, the stock trades at roughly 9.6 times earnings, and the EV/EBITDA multiple is just 2.6, both suggesting the market is not pricing in much growth. Where AB does score well is on dividend appeal (87th percentile), which fits the income-oriented case for holding a partnership-structured asset manager at this price. The short score of 52.5 sits near the midpoint of its recent range, consistent with a stock under moderate, not acute, short pressure. Wikipedia attention spiked recently, with a z-score of 2.1 against its own 90-day history, suggesting a burst of retail interest around the earnings-adjacent news cycle.

One ownership detail is worth flagging. Equitable Holdings holds a 68% stake in AB via a Schedule 13D/A filing, making it the dominant shareholder by a wide margin. That stake was last disclosed in July 2025. Per standard disclosure rules, the position is as-last-filed, and any changes below the 5% threshold may not trigger a further filing. Pathstone Family Office and Morgan Stanley Investment Management both added meaningfully in the June quarter, each building new or enlarged positions, while Merrill Lynch reduced by around 124,000 shares. None of these moves are large relative to the float, but they illustrate the stock's primary audience: wealth management platforms accumulating at current levels rather than trading around the news.

The next test is November 18. The question into that print is less about whether assets under management are growing and more about whether the slow target compression from analysts reflects genuine estimate risk, or simply a catch-up to a stock that has already derated.